On the sulfate ester of N-hydroxy-N-2-fluorenylacetamide as a key ultimate hepatocarcinogen in the rat.
D000081:Acetamides / Q000494:pharmacology; D000083:Acetanilides / Q000494:pharmacology; D000818:Animals; D002467:Cell Nucleus / Q000201:enzymology; D004336:Drug Antagonism; D005449:Fluorenes / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology*; D006900:Hydroxylation; D008099:Liver / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D009374:Neoplasms, Experimental; D051381:Rats; D013431:Sulfates / Q000494:pharmacology* / Q000652:urine; D014166:Transferases / Q000378:metabolism
D000081:Acetamides; D000083:Acetanilides; D005449:Fluorenes; D013431:Sulfates; D014166:Transferases